Transplant Infections 2016
DOI: 10.1007/978-3-319-28797-3_25
|View full text |Cite
|
Sign up to set email alerts
|

Cytomegalovirus Infection After Solid Organ Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
36
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(36 citation statements)
references
References 352 publications
0
36
0
Order By: Relevance
“…CMV is a beta herpes virus and, after bacterial pneumonia, is the second most common infection in lung transplant recipients (16), being one of the main cause of morbidity and mortality in these patients. It has been associated with tissue injury and infection, and some authors indicate CMV as a risk factor for acute and chronic rejection (17,18); finally, CMV may play an immunomodulatory role promoting several other opportunistic infections (19).…”
Section: CMVmentioning
confidence: 99%
“…CMV is a beta herpes virus and, after bacterial pneumonia, is the second most common infection in lung transplant recipients (16), being one of the main cause of morbidity and mortality in these patients. It has been associated with tissue injury and infection, and some authors indicate CMV as a risk factor for acute and chronic rejection (17,18); finally, CMV may play an immunomodulatory role promoting several other opportunistic infections (19).…”
Section: CMVmentioning
confidence: 99%
“…The seroprevalence of CMV in the United States is estimated to be high, with up to 90% of adults being seropositive . CMV establishes lifelong latency in many cell types, which allows for an efficient transmission of CMV to susceptible hosts during organ transplantation .…”
Section: Cytomegalovirus (Cmv)mentioning
confidence: 99%
“…CMV is one of the most common infectious complications affecting SOT patients and is associated with significant morbidity and occasional mortality . Risk factors for CMV disease include seronegative recipients of seropositive organs (D+/R−) and, to a lesser extent, seropositive recipients (D±/R+), lymphodepleting antibodies, and more potent immunosuppressive regimens . The risk of CMV disease also varies depending on the type of organ transplant: lung, small bowel, and pancreas transplant recipients generally have the highest risk, while liver and kidney recipients carry the lowest risk for CMV disease .…”
Section: Cytomegalovirus (Cmv)mentioning
confidence: 99%
See 1 more Smart Citation
“…14,[16][17][18][19] Relevant precedents are cytomegalovirus D + /R − and hepatitis B core antigen D + /R − LT, which are accepted by the LT community. 20,21 Given that HCV D + /R − LT is occurring without detailed, long-term outcomes data, the LT community will benefit from robust, well-designed randomized controlled trials (RCTs) assessing the outcomes of HCV D + /R − LT. Although some may question whether carrying out RCTs is ethical given the promising short-term preliminary data, to our knowledge, a reduction in wait-list time, as well as Until more data are reported, the risk-benefit calculus will have to be applied to each patient uniquely.…”
mentioning
confidence: 99%